Starpharma Holdings Limited (FRA:PQ6)

Starpharma Holdings Statistics

Total Valuation

FRA:PQ6 has a market cap or net worth of EUR 88.38 million. The enterprise value is 81.05 million.

Market Cap	88.38M
Enterprise Value	81.05M

Important Dates

The last earnings date was Monday, November 24, 2025.

Earnings Date	Nov 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	418.22M
Shares Outstanding	n/a
Shares Change (YoY)	+1.40%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	6.16%
Owned by Institutions (%)	27.01%
Float	343.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.06
PB Ratio	8.33
P/TBV Ratio	8.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.53
EV / Sales	24.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.35

Financial Position

The company has a current ratio of 4.32, with a Debt / Equity ratio of 0.13.

Current Ratio	4.32
Quick Ratio	3.76
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-0.35
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.41% and return on invested capital (ROIC) is -23.54%.

Return on Equity (ROE)	-42.41%
Return on Assets (ROA)	-20.07%
Return on Invested Capital (ROIC)	-23.54%
Return on Capital Employed (ROCE)	-49.47%
Revenue Per Employee	81,644
Profits Per Employee	-139,423
Employee Count	40
Asset Turnover	0.19
Inventory Turnover	4.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +267.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+267.27%
50-Day Moving Average	0.17
200-Day Moving Average	0.08
Relative Strength Index (RSI)	58.82
Average Volume (20 Days)	1,750

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:PQ6 had revenue of EUR 3.27 million and -5.58 million in losses. Loss per share was -0.01.

Revenue	3.27M
Gross Profit	-2.08M
Operating Income	-5.58M
Pretax Income	-5.58M
Net Income	-5.58M
EBITDA	-5.43M
EBIT	-5.58M
Loss Per Share	-0.01

Balance Sheet

The company has 8.60 million in cash and 1.34 million in debt, giving a net cash position of 7.26 million.

Cash & Cash Equivalents	8.60M
Total Debt	1.34M
Net Cash	7.26M
Net Cash Per Share	n/a
Equity (Book Value)	10.61M
Book Value Per Share	0.03
Working Capital	9.68M

Cash Flow

In the last 12 months, operating cash flow was -3.77 million and capital expenditures -23,447, giving a free cash flow of -3.80 million.

Operating Cash Flow	-3.77M
Capital Expenditures	-23,447
Free Cash Flow	-3.80M
FCF Per Share	n/a

Margins

Gross margin is -63.74%, with operating and profit margins of -170.77% and -170.77%.

Gross Margin	-63.74%
Operating Margin	-170.77%
Pretax Margin	-170.77%
Profit Margin	-170.77%
EBITDA Margin	-166.21%
EBIT Margin	-170.77%
FCF Margin	n/a

Dividends & Yields

FRA:PQ6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.40%
Shareholder Yield	-1.40%
Earnings Yield	-6.31%
FCF Yield	-4.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:PQ6 has an Altman Z-Score of -10.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.29
Piotroski F-Score	3